Buy Bellicum Pharmaceuticals Stock | BLCM Stock Price & Latest News | Public
BLCM

Bellicum Pharmaceuticals

$0.00 (0.00%)Today
    Small Market Cap

    About BLCM

    Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that contro...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    1.09
    -4.15
    -9.39
    -14.63
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$1.14

    Actual EPS
    Q4 2020

    Stats

    Market Cap$16,14M
    Volume477
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$27.90
    1 Year Low$2.74
    Open$3.17
    High$3.19
    Low$3.17

    Buy any stock with any amount of money.

    Download the App
    Download the app